0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Respiratory syncytial virus (RSV) - Epidemiology Forecast to 2028
Published Date: February 2019
|
Report Code: DELV-Epid-19
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Respiratory syncytial virus Epidemiology Forecast to 2028

Respiratory syncytial virus (RSV) - Epidemiology Forecast to 2028

Code: DELV-Epid-19
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Respiratory syncytial virus (RSV) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Respiratory syncytial virus (RSV) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Respiratory syncytial virus (RSV) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Respiratory syncytial virus (RSV) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Respiratory syncytial virus (RSV) outlook. It also includes the explanation of changing trends of epidemiology outlining the Respiratory syncytial virus (RSV) scenario.

Respiratory syncytial virus (RSV) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Respiratory syncytial virus (RSV) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Respiratory syncytial virus (RSV) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Respiratory syncytial virus (RSV) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Respiratory syncytial virus (RSV)

Key assessments
• Patient Segmentation in Respiratory syncytial virus (RSV)
• Respiratory syncytial virus (RSV) Risk & Burden
• Factors driving growth in a specific Respiratory syncytial virus (RSV) patient population

  1. Report Introduction
    2. Respiratory syncytial virus (RSV) Epidemiology Overview at a Glance
    2.1. Patient Share Distribution of Respiratory syncytial virus (RSV) in 2016
    2.2. Patient Share Distribution of Respiratory syncytial virus (RSV) in 2028
    3. Disease Background and Overview: Respiratory syncytial virus (RSV)
    3.1. Introduction
    3.2. Symptoms
    3.3. Etiology
    3.4. Risk Factors
    3.5. Pathophysiology
    3.6. Diagnosis
    3.7. Treatment
    4. Epidemiology and Patient Population
    4.1. Key Findings
    4.2. Total Prevalent/ Incident Patient Population of Respiratory syncytial virus (RSV) in 7MM
    4.3. Total Prevalent/ Incident Patient Population of Respiratory syncytial virus (RSV) in 7MM – By Countries
    5. Epidemiology of Respiratory syncytial virus (RSV) by Countries
    5.1. United States
    5.1.1. Assumptions and Rationale
    5.1.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.1.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV) *
    5.1.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.1.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    5.2. EU5
    5.3. Assumptions and Rationale
    5.4. Germany
    5.4.1. Assumptions and Rationale
    5.4.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.4.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV)*
    5.4.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.4.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    5.5. France
    5.5.1. Assumptions and Rationale
    5.5.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.5.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV)*
    5.5.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.5.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    5.6. Italy
    5.6.1. Assumptions and Rationale
    5.6.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.6.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV)*
    5.6.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.6.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    5.7. Spain
    5.7.1. Assumptions and Rationale
    5.7.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.7.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV)*
    5.7.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.7.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    5.8. United Kingdom
    5.8.1. Assumptions and Rationale
    5.8.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.8.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV)*
    5.8.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.8.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    5.9. Japan
    5.9.1. Assumptions and Rationale
    5.9.2. Prevalent/Incident Cases of the Respiratory syncytial virus (RSV)
    5.9.3. Sub-Type Specific cases of the Respiratory syncytial virus (RSV)*
    5.9.4. Sex- Specific Cases of the Respiratory syncytial virus (RSV)*
    5.9.5. Diagnosed Cases of the Respiratory syncytial virus (RSV)
    6. Unmet Needs of the Respiratory syncytial virus (RSV)
    7. Appendix
    8. Report Methodology
    8.1. Sources
    9. DelveInsight Capabilities
    10. Disclaimer
    11. About DelveInsight
    *Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in 7MM
Table 2: Total Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in France (2016-2028) *
Table 14: Diagnosed Cases of the Respiratory syncytial virus (RSV) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Respiratory syncytial virus (RSV) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028)


List of Figures

Figure 1: Total Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Respiratory syncytial virus (RSV) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Respiratory syncytial virus (RSV) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Respiratory syncytial virus (RSV) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Respiratory syncytial virus (RSV) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global and United States Tick borne Encephalitis Inactivated Vaccine Market Insights Forecast to 2027
Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34O6484
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China STDs Diagnosis Market Size Status and Forecast 2021 2027
Global and China STDs Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-14L6711
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China Seasonal Influenza Vaccines Therapeutics Market Size Status and Forecast 2021 2027
Global and China Seasonal Influenza Vaccines Therapeutics Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-23O3163
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global and Japan Meningococcal Disease Drugs Market Insights Forecast to 2027
Global and Japan Meningococcal Disease Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-13H6796
Sat Sep 04 00:00:00 UTC 2021

Add to Cart